信邦制药 (002390)
Guizhou Xinbang Pharmaceutical Co.,Ltd.
K-Line Chart
No K-line data
Stock Details
1. Key Indicators
- Total Shares(W): 194385.19
- Circulating A-Shares(W): 192781.82
- Earnings Per Share(RMB): 0.0803
- Net Assets Per Share(RMB): 3.4720
- Operating Revenue(W RMB): 426628.53
- Total Profit(W RMB): 22522.74
- Net Profit Attributable to Parent(W RMB): 15232.50
- Net Profit Growth Rate(%): -13.74
- Weighted Return on Equity(%): 2.2500
- Operating Cash Flow Per Share(RMB): 0.2380
- Undistributed Profit Per Share(RMB): 0.2548
- Capital Reserve Per Share(RMB): 2.2651
2. Main Business
The main business covers:
- Medical Services
- Pharmaceutical Distribution
- Pharmaceutical Manufacturing
3. Company Basic Information
- Company Name: Guizhou Xinbang Pharmaceutical Co., Ltd.
- Listing Date: 2010-04-16
- Industry: Wholesale Trade
- Address: No. 83, Xintian Avenue North Section, Wudang District, Guiyang City, Guizhou Province
- Website: www.xinbang.com
- Company Profile：The company's predecessor was Guizhou Xinbang Pharmaceutical Co., Ltd., established on January 27, 1995. It was established as a joint-stock company on February 2, 2000, with approval from the Guizhou Provincial Government. Its share capital and structure were standardized in 2001, resulting in a total share capital of 20.967 million shares.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Guizhou Jinyu Industrial Investment Partnership (Limited Partnership) | General Legal Person | 36000.00 | 18.67 |
| 2 | Harbin Yuxi Venture Capital Co., Ltd. | General Legal Person | 35876.43 | 18.61 |
| 3 | Hong Kong Securities Clearing Company Ltd. | Northbound Capital | 2174.17 | 1.13 |
| 4 | UCPHARM COMPANY LIMITED | General Legal Person | 1917.95 | 0.99 |
| 5 | Southern China Securities CSI 1000 ETF | Fund | 1067.60 | 0.55 |
| 6 | Dacheng Fengxiang Return Hybrid Securities Investment Fund Class A | Fund | 24.64 | 0.01 |
| 7 | Dacheng Absolute Return Strategy Hybrid Fund Class A | Fund | 7.64 | 0.00 |
| 8 | ABC-CA CSI 1000 Index Enhanced Securities Investment Fund Class A | Fund | 4.91 | 0.00 |
5. Concept Sectors
- Venture Capital
- Elderly Care
- Private Hospitals
- Gene Concept
- Smart Healthcare
- Rural Revitalization
- Industrial Hemp
- Medical Aesthetics
- Family Doctor
- Hepatitis Concept
- Margin Trading & Securities Lending
- Below Net Asset Value
Remarks
- Data update date: 2026-01-01
- Data source: Public Market Information